Item:Q190706: Difference between revisions

@@ redirect / redirect @@
+Q3698691
@@ label / fr / label / fr @@
-- MIMEDI
@@ label / en / label / en @@
-— MIMEDI
@@ description / en / description / en @@
-Project in France financed by DG Regio
@@ description / fr / description / fr @@
-Projet en France financé par DG Regio
@@ Property / French Kohesio ID @@
@@ Property / French Kohesio ID: 10341 / rank @@
-Normal rank
@@ Property / instance of @@
-Kohesio project
@@ Property / instance of: Kohesio project / rank @@
-Normal rank
@@ Property / country @@
-France
@@ Property / country: France / rank @@
-Normal rank
@@ Property / EU contribution @@
-,211,026.83 EuroAmount 10,211,026.83 Euro
Unit Euro
-Amount
+,211,026.83 Euro
-Unit
+Euro
@@ Property / EU contribution: 10,211,026.83 Euro / rank @@
-Normal rank
@@ Property / budget @@
-,614,711.32 EuroAmount 13,614,711.32 Euro
Unit Euro
-Amount
+,614,711.32 Euro
-Unit
+Euro
@@ Property / budget: 13,614,711.32 Euro / rank @@
-Normal rank
@@ Property / postal code @@
@@ Property / postal code: 25030 / rank @@
-Normal rank
@@ Property / start time @@
-December 2017Timestamp +2017-12-01T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2017-12-01T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / start time: 1 December 2017 / rank @@
-Normal rank
@@ Property / end time @@
-November 2021Timestamp +2021-11-30T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2021-11-30T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / end time: 30 November 2021 / rank @@
-Normal rank
@@ Property / beneficiary name (string) @@
-Université de Franche-Comté
@@ Property / beneficiary name (string): Université de Franche-Comté / rank @@
-Normal rank
@@ Property / summary @@
-Les médicaments innovants (MédI) ont récemment émergé afin de proposer de nouvelles solutions de traitement pour les patients en impasse thérapeutique. Ces MédI sont basés sur l’utilisation de cellules « médicaments ». Or, la fabrication de ces médicaments nécessite de mettre en oeuvre des technologies complexes et donc coûteuses. MiMédi a pour ambition de rationaliser leur fabrication en apportant de nouvelles solutions techniques et en optimisant l’ensemble des étapes nécessaires à leur production. Pour se faire, MiMédi associe des laboratoires de recherche et des industriels francs-comtois aussi bien issus des sciences de l’ingénieur que de l’ingénierie cellulaire. (French)
-Normal rank
@@ Property / summary @@
-Innovative medicines (Médi) have recently emerged in order to propose new treatment solutions for patients in therapeutic impasse. These are based on the use of medicines cells. However, the manufacture of these medicines requires the implementation of complex and thus expensive technologies. Migri’s ambition is to streamline production by providing new technical solutions and optimising all the steps needed to produce them. In order to get involved, Migradi brings together research and industrial research laboratories from both the engineering and the cellular engineering sciences. (English)
-Normal rank
@@ Property / intervention field @@
-Technology transfer and university-enterprise cooperation primarily benefiting SMEs
-Normal rank
@@ Property / coordinate location @@
-°14'23.03"N, 6°0'44.14"ELatitude 47.239733666667
Longitude 6.0122559333333
Precision 1.0E-5
Globe http://www.wikidata.org/entity/Q2
-Latitude
+.239733666667
-Longitude
+.0122559333333
-Precision
+.0E-5
-Globe
+http://www.wikidata.org/entity/Q2
@@ Property / coordinate location: 47°14'23.03"N, 6°0'44.14"E / rank @@
-Normal rank
@@ Property / financed by @@
-European Union
@@ Property / financed by: European Union / rank @@
-Normal rank
@@ Property / financed by @@
-Directorate-General for Regional and Urban Policy
-Normal rank
@@ Property / programme @@
-Franche-Comté et Jura - ERDF/ESF
@@ Property / programme: Franche-Comté et Jura - ERDF/ESF / rank @@
-Normal rank
@@ Property / co-financing rate @@
-.0 percentAmount 75.0 percent
Unit percent
-Amount
+.0 percent
-Unit
+percent
@@ Property / co-financing rate: 75.0 percent / rank @@
-Normal rank
@@ Property / beneficiary @@
-Q2537920 (Deleted Item)
@@ Property / beneficiary: Q2537920 (Deleted Item) / rank @@
-Normal rank
@@ Property / ID used by InfoRegio @@
@@ Property / ID used by InfoRegio: 4607 / rank @@
-Normal rank
@@ Property / info Regio url @@
-https://ec.europa.eu/regional_policy/en/projects/europe/mimedi-optimiser-la-fabrication-de-medicaments-innovants-en-evitant-le-recours-aux-salles-blanches
-Normal rank
@@ Property / image url @@
-https://ec.europa.eu/regional_policy/rest/projects/upload/4607.jpg
-Normal rank
-summary: Device for biological element sorting by acoustophoresis. (English)
-copyright: Quarroz – FEMTO, Univ-Franche-Comte 2018
@@ Property / fund @@
-European Regional Development Fund
@@ Property / fund: European Regional Development Fund / rank @@
-Normal rank

Latest revision as of 13:44, 16 May 2022

Redirect to:

Item:Q3698691

Item:Q190706: Difference between revisions

Latest revision as of 13:44, 16 May 2022

Navigation menu

Search